These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1008360)

  • 21. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The polychemotherapeutic treatment of advanced breast cancer.
    Brown I; Arthur K; Banks AJ; Bond WH; Chowdhury MS; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ward HW
    Clin Oncol; 1977 Jun; 3(2):183-9. PubMed ID: 872472
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytostatic therapy in metastasizing breast cancer].
    Gynning I; Mattsson W
    Lakartidningen; 1978 Apr; 75(15):1512-5. PubMed ID: 651418
    [No Abstract]   [Full Text] [Related]  

  • 28. [Integrated chemotherapy and radiotherapy of inoperable bronchial carcinoma: preliminary results in 50 cases (author's transl)].
    Seeber S; Schmidt CG; Holfeld H; Scherer E
    Dtsch Med Wochenschr; 1977 Feb; 102(5):147-52. PubMed ID: 832600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
    Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
    Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
    Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experiences with cytostatic treatment of malignant tumors].
    Siering H; Felsch G; Barthel E
    Z Gesamte Inn Med; 1976 Feb; 31(3):65-9. PubMed ID: 960897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W; Nagel G; Senn HJ
    Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytostatic therapy of inoperable carcinomas].
    Baumgartner G
    Wien Med Wochenschr; 1976 Jan; 126(5):59-61. PubMed ID: 986106
    [No Abstract]   [Full Text] [Related]  

  • 34. A five-drug combination in the treatment of metastatic breast cancer.
    Falkson G; Falkson HC
    Cancer Clin Trials; 1981; 4(1):81-5. PubMed ID: 7214665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of primary and secondary liver tumors using a combination of chemotherapy and surgery].
    Pettavel J; Morgenthaler FR
    Schweiz Med Wochenschr; 1975 May; 105(18):596-8. PubMed ID: 124947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Induction chemotherapy in high risk breast cancer. Results of a prospective therapeutic study (author's transl)].
    Chauvergne J; Durand M; Hoerni B; Cohen P; Lagarde C
    Bull Cancer; 1979; 66(1):9-16. PubMed ID: 420953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapeutic combinations of mutually potentializing drugs. 1-Application to the treatment of breast cancers].
    Pouillart P; Schwarzenberg L; Amiel JL; Mathé G; Huguenin P; Morin P; Baron A; Laparre Ch; Parrot R
    Nouv Presse Med; 1975 Mar; 4(10):713-6. PubMed ID: 1129034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Status and problems of the treatment of metastatic rectal cancer].
    Lehnert M
    Acta Med Austriaca Suppl; 1979; 6():330-1. PubMed ID: 299223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
    Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.